Test-retest repeatability of quantitative radiomics features of FDG PET/CT studies in patients with diffuse large B cell lymphoma

Test-retest repeatability of quantitative radiomics features of FDG PET/CT studies in patients with diffuse large B cell lymphoma - Radiomics TRT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48134

Enrollment

Registered

2019-06-21

Start date

2020-02-03

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diffuse large B cell lymphoma lymph node cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patient age 18 years or older - Diagnosed with diffuse large B cell lymphoma - At least one tumour with diameter > 3cm (to minimize partial volume effects) - Able to remain supine for 60 minutes in the PET-CT scanner - Written and signed informed consent

Exclusion criteria

Exclusion criteria: - Chemotherapy in the past 4 weeks - Multiple malignancies - Pregnant or lactating patients - Metal implants (e.g. pacemakers) - Any medical, physiological or social condition that may interfere with the subject*s safety and participation in the study, will lead to exclusion from this study

Design outcomes

Primary

Measure	Time frame
The test-retest repeatability of radiomics features with different image reconstruction settings.	—

Countries

Netherlands

Outcome results